Biogen (BIIB) Enterprise Value (2009 - 2026)
Biogen (BIIB) recorded Enterprise Value of $30.64 billion in Q2 2026, up 95.7% from $15.65 billion a year earlier and up 34.5% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Enterprise Value (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Enterprise Value came in at $18.58 billion as of Jun 30, 2026, up 106.9% year-over-year; for FY2025, it came in at $22.02 billion, up 10.5% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $19.92 billion in FY2024 (-45.3%), $36.45 billion in FY2023 (+4.2%), $34.97 billion in FY2022 (+10.9%) and $31.53 billion in FY2021 (-9.1%).
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q2 2024.
- On a year-over-year basis, Enterprise Value has increased for three consecutive quarters, with an average decline of 7.9% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 95.7% in Q2 2026, against a decline of 50.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.78 billion (Q1 2026), $22.02 billion (Q4 2025) and $16.59 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.64 Bn |
| Mar 31, 2026 | 22.78 Bn |
| Dec 31, 2025 | 22.02 Bn |
| Sep 30, 2025 | 16.59 Bn |
| Jun 30, 2025 | 15.65 Bn |
| Mar 31, 2025 | 17.45 Bn |
| Dec 31, 2024 | 19.92 Bn |
| Sep 30, 2024 | 26.55 Bn |
| Jun 30, 2024 | 31.86 Bn |
| Mar 31, 2024 | 30.32 Bn |
| Dec 31, 2023 | 36.45 Bn |
| Sep 30, 2023 | 34.95 Bn |
| Jun 30, 2023 | 35.17 Bn |
| Mar 31, 2023 | 35.19 Bn |
| Dec 31, 2022 | 34.97 Bn |
| Sep 30, 2022 | 33.53 Bn |
| Jun 30, 2022 | 24.79 Bn |
| Mar 31, 2022 | 27.07 Bn |
| Dec 31, 2021 | 31.53 Bn |
| Sep 30, 2021 | 39.07 Bn |
API Access
Biogen Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();